In her role at J&J, Dr. Nicholson develops an overarching women’s health strategy with a focus on maternal health. She has carried this torch by driving investment in policies and solutions to address the U.S. maternal mortality crisis, partnering with national maternal health leaders to identify and take action toward solutions. She has hosted maternal
Jen has volunteered her time to help educate federal legislators on Biogen’s public policy goals. She has traveled to DC several times to meet with Biogen’s Government Affairs team and members of Congress. She has a unique talent for explaining the complexities of drug pricing and value-based contracting so that members of Congress and their
Anthony is one of Novartis’ champions who has been a great advocate for Novartis and patients, meeting with key members of state legislatures across the U.S. He has gone above and beyond to educate policymakers about the importance of R&D and innovative therapies while highlighting the challenges and expenses of bringing new medicines to the
Dr. Osei-Wusu provides critical input into the strategy, development and implementation of studies in the company’s cardiovascular program. She has represented Novartis at both the American College of Cardiology and the American Heart Association Scientific Congresses. And is also an active member of Women of Color in Pharma. Over the last year, she has partnered
Dr. Osinusi advocates for policies that encourage therapies to combat emerging viruses. This includes educating policymakers and administration officials on how intellectual property protections enabled the R&D that was so crucial to Gilead’s response to the COVID-19 pandemic. It also includes her work to explain how policies that undermine IP protections, like the TRIPS waiver,
Chris is currently the Senior Director for Clinical Laboratory Sciences with over 25 years of experience with Eli Lilly and Company. Chris and Dr. Janelle Sabo helped develop Indiana’s largest COVID-19 reference lab that helped the state almost immediately increase its testing capacity from approximately 300 tests per day to 30,000 tests per day.
Caroline has created and launched an industry-leading, first- and only-of-its-kind program for increasingly influential online patient health advocates. HealtheVoices, now in its third year, brings together online patient advocates for a weekend of learning, growing and mutual support.
Dr. Peakman proactively educates policymakers on the importance of the industry’s work. She represented Pfizer at the 2018 Connecticut Pharmaceutical Researchers’ Day at the Capitol and worked with the Pfizer Legislative Team to advocate before the Rhode Island legislature. Dr. Peakman serves on the Board of Directors for the United Way of Southeastern Connecticut and
(Sanofi) – In 2014 Jason brought his incredible energy to Sanofi’s Corporate Affairs department during a field-rotation program specifically working on employee civic action initiatives. His enthusiasm helped drive strong employee participation in company activations and voter education and registration events.
Outside of his role as a Senior Regional Director, Jeff frequently represents Bristol Myers Squibb (BMS) at meetings and events with federal and state elected officials and with other key policymaker stakeholders. He is a passionate advocate for the patients the industry serves. He has been instrumental in getting his colleagues involved by recruiting new